"2018 was an exciting and productive year for kidney cancer research," write Amr A. Elbakry, MBBCh, MSc, and Ketan K. Badani, MD.
Amr A. Elbakry, MBBCh, MSc
Advertisement
Articles by Amr A. Elbakry, MBBCh, MSc
Advertisement
Latest Updated Articles
- RCC 2018: Top advances in treatment of localized, advanced disease
Published: January 18th 2019 | Updated:
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves first-line Zenflow system for the treatment of BPH
2
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
3
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
4
EMA recommends conditional approval of Anktiva in BCG-unresponsive NMIBC
5
